Dabur India key Products/Revenue Segments include Personal Care, Other Operating Revenue and Scrap for the year ending 31-Mar-2022.

Dabur India, incorporated in the year 1975, is a Large Cap company (having a market cap of Rs 95763.82 Crore) operating in FMCG sector.

Dabur India, incorporated in the year 1975, is a Large Cap company (having a market cap of Rs 96428.23 Crore) operating in FMCG sector.

Promoters held 67.24 per cent stake in the company as of 30-Sep-2022, while FIIs owned 20.23 per cent, DIIs 6.43 per cent.

Dabur India Ltd. key Products/Revenue Segments include Personal Care, Other Operating Revenue and Scrap for the year ending 31-Mar-2022.

Dharmesh Shah recommended to keep a stop loss at Rs 439.

The company has reported a consolidated sales of Rs 2,273.29 crore.

The company has reported consolidated sales of Rs 2,273.29 crore.

Buy Dabur India at a price target of Rs 355 and a stop loss at Rs 323 from entry point.

Buy Dabur India at a price target of Rs 340 and a stop loss at Rs 327 from entry point.

Buy Dabur India at a price target of Rs 335 and a stop loss at Rs 313 from entry point.

A cost of Rs 5,000 was today imposed by a court here on Delhi Chief Minister Sheila Dikshit for her non-appearance in a defamation case.

The Delhi Police today said no criminal offence is made out in the complaint filed by ex-BJP chief Vijender Gupta against Chief Minister Sh...

The Delhi High Court today issued notice to Dikshit on a petition filed by BJP leader Vijender Gupta challenging a trial court order for fr...

The PE fund is likely to pump in money into the primary healthcare chain in a phased manner, in at least two tranches.

HC today stayed screening or telecast of an advertisement featuring Amitabh Bachchan for Emami Ltd's product Navratna oil.

The Burmans, promoters of Dabur Pharmaceuticals, have sold the company as it would grow faster by being part of a company with global reach.